VANGUARD GROUP INC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 30 filers reported holding REPROS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$486,000
+89.8%
735,447
-8.3%
0.00%
Q3 2017$256,000
-30.1%
801,737
+0.9%
0.00%
Q2 2017$366,000
-65.7%
794,303
-10.7%
0.00%
Q1 2017$1,068,000
-8.3%
889,850
+0.8%
0.00%
Q4 2016$1,165,000
-41.9%
882,436
-8.0%
0.00%
Q3 2016$2,005,000
+24.0%
958,977
-4.5%
0.00%
Q2 2016$1,617,000
+100.9%
1,004,041
+21.1%
0.00%
Q1 2016$805,000
-19.6%
829,431
+0.3%
0.00%
Q4 2015$1,001,000
-82.3%
827,190
+8.4%
0.00%
Q3 2015$5,668,000
+12.7%
762,838
+8.5%
0.00%
Q2 2015$5,029,000
-17.2%
703,287
-0.5%
0.00%
Q1 2015$6,073,000
-6.3%
706,907
+8.7%
0.00%
Q4 2014$6,483,000
-0.5%
650,225
-1.2%
0.00%
-100.0%
Q3 2014$6,513,000
-41.3%
657,860
+2.6%
0.00%0.0%
Q2 2014$11,097,000
+2.7%
641,383
+5.3%
0.00%0.0%
Q1 2014$10,806,000
+3.6%
609,134
+6.9%
0.00%0.0%
Q4 2013$10,427,000
-29.1%
569,763
+3.8%
0.00%0.0%
Q3 2013$14,712,000
+53.2%
548,958
+5.4%
0.00%0.0%
Q2 2013$9,606,000520,6580.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders